Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer.

Arbour KC, Mezquita L, Long N, Rizvi H, Auclin E, Ni A, Martínez-Bernal G, Ferrara R, Lai WV, Hendriks LEL, Sabari JK, Caramella C, Plodkowski AJ, Halpenny D, Chaft JE, Planchard D, Riely GJ, Besse B, Hellmann MD.

J Clin Oncol. 2018 Aug 20:JCO2018790006. doi: 10.1200/JCO.2018.79.0006. [Epub ahead of print]

PMID:
30125216
2.

Brain imaging in early stage non-small cell lung cancer: still a controversial topic?

Schoenmaekers JJAO, Dingemans AC, Hendriks LEL.

J Thorac Dis. 2018 Jul;10(Suppl 18):S2168-S2171. doi: 10.21037/jtd.2018.06.68. No abstract available.

3.

The Prevention of Brain Metastases in Non-Small Cell Lung Cancer by Prophylactic Cranial Irradiation.

Witlox WJA, Ramaekers BLT, Zindler JD, Eekers DBP, van Loon JGM, Hendriks LEL, Dingemans AC, De Ruysscher DKM.

Front Oncol. 2018 Jul 26;8:241. doi: 10.3389/fonc.2018.00241. eCollection 2018. Review.

4.

What you see is (not) what you get: tools for a non-radiologist to evaluate image quality in lung cancer.

de Jong EEC, Hendriks LEL, van Elmpt W, Gietema HA, Hofman PAM, De Ruysscher DKM, Dingemans AC.

Lung Cancer. 2018 Sep;123:112-115. doi: 10.1016/j.lungcan.2018.07.014. Epub 2018 Jul 18.

PMID:
30089580
5.

Therapist rotation: a novel approach for implementation of trauma-focused treatment in post-traumatic stress disorder.

Van Minnen A, Hendriks L, Kleine R, Hendriks GJ, Verhagen M, De Jongh A.

Eur J Psychotraumatol. 2018 Jul 17;9(1):1492836. doi: 10.1080/20008198.2018.1492836. eCollection 2018.

6.

Measuring emotional support in family networks: Adapting the Family Network Method for individuals with a mild intellectual disability.

Giesbers SAH, Tournier T, Hendriks L, Hastings RP, Jahoda A, Embregts PJCM.

J Appl Res Intellect Disabil. 2018 Jul 13. doi: 10.1111/jar.12512. [Epub ahead of print]

PMID:
30004149
7.

Invasive Aspergillosis Mimicking Metastatic Lung Cancer.

Vanfleteren MJEGW, Dingemans AC, Surmont VF, Vermaelen KY, Postma AA, Oude Lashof AML, Pitz CCM, Hendriks LEL.

Front Oncol. 2018 Jun 5;8:188. doi: 10.3389/fonc.2018.00188. eCollection 2018.

8.

New windows open for immunotherapy in lung cancer.

Hendriks L, Besse B.

Nature. 2018 Jun;558(7710):376-377. doi: 10.1038/d41586-018-05312-9. No abstract available.

PMID:
29907821
9.

Non-small cell lung cancer brain metastases and the immune system: From brain metastases development to treatment.

El Rassy E, Botticella A, Kattan J, Le Péchoux C, Besse B, Hendriks L.

Cancer Treat Rev. 2018 Jul;68:69-79. doi: 10.1016/j.ctrv.2018.05.015. Epub 2018 May 31. Review.

10.

Stereotactic Radiosurgery in the Management of Patients With Brain Metastases of Non-Small Cell Lung Cancer: Indications, Decision Tools and Future Directions.

Hartgerink D, van der Heijden B, De Ruysscher D, Postma A, Ackermans L, Hoeben A, Anten M, Lambin P, Terhaag K, Jochems A, Dekker A, Schoenmaekers J, Hendriks L, Zindler J.

Front Oncol. 2018 May 9;8:154. doi: 10.3389/fonc.2018.00154. eCollection 2018. Review.

11.

Association of molecular status and metastatic organs at diagnosis in patients with stage IV non-squamous non-small cell lung cancer.

Kuijpers CCHJ, Hendriks LEL, Derks JL, Dingemans AC, van Lindert ASR, van den Heuvel MM, Damhuis RA, Willems SM.

Lung Cancer. 2018 Jul;121:76-81. doi: 10.1016/j.lungcan.2018.05.006. Epub 2018 May 15.

12.

Unbiased Combinatorial Screening Identifies a Bispecific IgG1 that Potently Inhibits HER3 Signaling via HER2-Guided Ligand Blockade.

Geuijen CAW, De Nardis C, Maussang D, Rovers E, Gallenne T, Hendriks LJA, Visser T, Nijhuis R, Logtenberg T, de Kruif J, Gros P, Throsby M.

Cancer Cell. 2018 May 14;33(5):922-936.e10. doi: 10.1016/j.ccell.2018.04.003.

PMID:
29763625
13.

Analysis of Inorganic Nanoparticles by Single-particle Inductively Coupled Plasma Time-of-Flight Mass Spectrometry.

Hendriks L, Gundlach-Graham A, Günther D.

Chimia (Aarau). 2018 Apr 25;72(4):221-226. doi: 10.2533/chimia.2018.221.

PMID:
29720313
14.

Water dispersible surface-functionalized platinum/carbon nanorattles for size-selective catalysis.

Hofer CJ, Grass RN, Schneider EM, Hendriks L, Herzog AF, Zeltner M, Günther D, Stark WJ.

Chem Sci. 2017 Oct 30;9(2):362-367. doi: 10.1039/c7sc03785f. eCollection 2018 Jan 14.

15.

Are We Ready to Safely Combine Anti-PD-1/PD-L1 with Cranial Irradiation in Non-Small Cell Lung Cancer Patients?

Levy A, Hendriks LE, Faivre-Finn C.

J Thorac Oncol. 2018 Apr;13(4):475-477. doi: 10.1016/j.jtho.2018.02.019. No abstract available.

PMID:
29576287
16.

Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group survey.

Levy A, Faivre-Finn C, Hasan B, De Maio E, Berghoff AS, Girard N, Greillier L, Lantuéjoul S, O'Brien M, Reck M, Dingemans AC, Novello S, Berghmans T, Besse B, Hendriks L; Young Investigators EORTC Lung Cancer Group (YI EORTC LCG).

Eur J Cancer. 2018 Apr;93:37-46. doi: 10.1016/j.ejca.2018.01.067. Epub 2018 Feb 21.

PMID:
29477100
17.

Current perspective: Osimertinib-induced QT prolongation: new drugs with new side-effects need careful patient monitoring.

Schiefer M, Hendriks LEL, Dinh T, Lalji U, Dingemans AC.

Eur J Cancer. 2018 Mar;91:92-98. doi: 10.1016/j.ejca.2017.12.011.

PMID:
29413968
18.

Intensive prolonged exposure therapy for chronic PTSD patients following multiple trauma and multiple treatment attempts.

Hendriks L, de Kleine RA, Broekman TG, Hendriks GJ, van Minnen A.

Eur J Psychotraumatol. 2018 Jan 30;9(1):1425574. doi: 10.1080/20008198.2018.1425574. eCollection 2018.

19.

Intensive prolonged exposure treatment for adolescent complex posttraumatic stress disorder: a single-trial design.

Hendriks L, de Kleine RA, Heyvaert M, Becker ES, Hendriks GJ, van Minnen A.

J Child Psychol Psychiatry. 2017 Nov;58(11):1229-1238. doi: 10.1111/jcpp.12756. Epub 2017 Jun 14.

PMID:
29057522
20.

Patient-reported outcomes in newly diagnosed early rheumatoid arthritis patients treated to target with a tocilizumab- or methotrexate-based strategy.

Teitsma XM, Jacobs JWG, Welsing PMJ, Pethö-Schramm A, Borm MEA, Hendriks L, Denissen NHAM, van Laar JM, Lafeber FPJG, Bijlsma JWJ.

Rheumatology (Oxford). 2017 Dec 1;56(12):2179-2189. doi: 10.1093/rheumatology/kex319.

PMID:
29029185
21.

Systematic literature review comparing rapid 3-dose administration of the GSK tick-borne encephalitis vaccine with other primary immunization schedules.

Galgani I, Bunge EM, Hendriks L, Schludermann C, Marano C, De Moerlooze L.

Expert Rev Vaccines. 2017 Sep;16(9):919-932. doi: 10.1080/14760584.2017.1358620. Epub 2017 Aug 4. Review.

PMID:
28770638
22.

The Current Role of Whole Brain Radiation Therapy in Non-Small Cell Lung Cancer Patients.

Loganadane G, Hendriks L, Le Péchoux C, Levy A.

J Thorac Oncol. 2017 Oct;12(10):1467-1477. doi: 10.1016/j.jtho.2017.07.006. Epub 2017 Jul 19. Review.

PMID:
28733269
23.

A new approach for generating bispecific antibodies based on a common light chain format and the stable architecture of human immunoglobulin G1.

De Nardis C, Hendriks LJA, Poirier E, Arvinte T, Gros P, Bakker ABH, de Kruif J.

J Biol Chem. 2017 Sep 1;292(35):14706-14717. doi: 10.1074/jbc.M117.793497. Epub 2017 Jun 27.

24.

Harm expectancy violation during exposure therapy for posttraumatic stress disorder.

de Kleine RA, Hendriks L, Becker ES, Broekman TG, van Minnen A.

J Anxiety Disord. 2017 Jun;49:48-52. doi: 10.1016/j.janxdis.2017.03.008. Epub 2017 Mar 31.

PMID:
28399468
25.

Heat shock protein antagonists in early stage clinical trials for NSCLC.

Hendriks LEL, Dingemans AC.

Expert Opin Investig Drugs. 2017 May;26(5):541-550. doi: 10.1080/13543784.2017.1302428. Epub 2017 Mar 8. Review.

PMID:
28274158
26.

Screening for Brain Metastases in Resectable Non-Small Cell Lung Cancer.

Hendriks LE, Hochstenbag M, Dingemans AM.

J Thorac Oncol. 2017 Mar;12(3):e21. doi: 10.1016/j.jtho.2016.11.2220. No abstract available.

27.

Dichotomous ALK-IHC Is a Better Predictor for ALK Inhibition Outcome than Traditional ALK-FISH in Advanced Non-Small Cell Lung Cancer.

van der Wekken AJ, Pelgrim R, 't Hart N, Werner N, Mastik MF, Hendriks L, van der Heijden EHFM, Looijen-Salamon M, de Langen AJ, Staal-van den Brekel J, Riemersma S, van den Borne BE, Speel EJM, Dingemans AC, Hiltermann TJN, van den Berg A, Timens W, Schuuring E, Groen HJM.

Clin Cancer Res. 2017 Aug 1;23(15):4251-4258. doi: 10.1158/1078-0432.CCR-16-1631. Epub 2017 Feb 9.

28.

Use of Systemic Therapy Concurrent With Cranial Radiotherapy for Cerebral Metastases of Solid Tumors.

Verduin M, Zindler JD, Martinussen HM, Jansen RL, Croes S, Hendriks LE, Eekers DB, Hoeben A.

Oncologist. 2017 Feb;22(2):222-235. doi: 10.1634/theoncologist.2016-0117. Epub 2017 Feb 6.

29.

Management of stage I and II nonsmall cell lung cancer.

McDonald F, De Waele M, Hendriks LE, Faivre-Finn C, Dingemans AC, Van Schil PE.

Eur Respir J. 2017 Jan 3;49(1). pii: 1600764. doi: 10.1183/13993003.00764-2016. Print 2017 Jan. Review.

30.

Development of symptomatic brain metastases after chemoradiotherapy for stage III non-small cell lung cancer: Does the type of chemotherapy regimen matter?

Hendriks LE, Brouns AJ, Amini M, Uyterlinde W, Wijsman R, Bussink J, Biesma B, Oei SB, Stigt JA, Bootsma GP, Belderbos JS, De Ruysscher DK, Van den Heuvel MM, Dingemans AC.

Lung Cancer. 2016 Nov;101:68-75. doi: 10.1016/j.lungcan.2016.09.008. Epub 2016 Sep 9.

31.

Stage III Non-Small Cell Lung Cancer in the elderly: Patient characteristics predictive for tolerance and survival of chemoradiation in daily clinical practice.

Driessen EJ, Bootsma GP, Hendriks LE, van den Berkmortel FW, Bogaarts BA, van Loon JG, Dingemans AC, Janssen-Heijnen ML.

Radiother Oncol. 2016 Oct;121(1):26-31. doi: 10.1016/j.radonc.2016.07.025. Epub 2016 Aug 10.

PMID:
27522577
32.

Early Weight Loss during Chemoradiotherapy Has a Detrimental Impact on Outcome in NSCLC.

Sanders KJ, Hendriks LE, Troost EG, Bootsma GP, Houben RM, Schols AM, Dingemans AM.

J Thorac Oncol. 2016 Jun;11(6):873-9. doi: 10.1016/j.jtho.2016.02.013. Epub 2016 Mar 3.

33.

Proposals for the M-descriptors of the Eight TNM Classification for Non-Small Cell Lung Cancer: Are More Data Needed?

Hendriks LE, Dingemans AM, De Ruysscher D.

J Thorac Oncol. 2016 Mar;11(3):e42-3. doi: 10.1016/j.jtho.2015.11.013. No abstract available.

34.

Effect of Bisphosphonates, Denosumab, and Radioisotopes on Bone Pain and Quality of Life in Patients with Non-Small Cell Lung Cancer and Bone Metastases: A Systematic Review.

Hendriks LE, Hermans BC, van den Beuken-van Everdingen MH, Hochstenbag MM, Dingemans AM.

J Thorac Oncol. 2016 Feb;11(2):155-73. doi: 10.1016/j.jtho.2015.10.001. Epub 2015 Dec 22. Review.

35.

Towards a framework in interaction training for staff working with clients with intellectual disabilities and challenging behaviour.

Willems A, Embregts P, Hendriks L, Bosman A.

J Intellect Disabil Res. 2016 Feb;60(2):134-48. doi: 10.1111/jir.12249. Epub 2015 Dec 28.

PMID:
26708920
36.

Clinical features of large cell neuroendocrine carcinoma: a population-based overview.

Derks JL, Hendriks LE, Buikhuisen WA, Groen HJ, Thunnissen E, van Suylen RJ, Houben R, Damhuis RA, Speel EJ, Dingemans AM.

Eur Respir J. 2016 Feb;47(2):615-24. doi: 10.1183/13993003.00618-2015. Epub 2015 Nov 5.

37.

An Uncommon Presentation of Brain Metastases in a Lung Cancer Patient.

Hendriks L, Dingemans AM, Lammens M, Anten MM, van den Heuvel MM, Postma LA.

J Thorac Oncol. 2015 Nov;10(11):1655-6. doi: 10.1097/JTO.0000000000000602. No abstract available.

38.

Comparison of clinical outcome after first-line platinum-based chemotherapy in different types of KRAS mutated advanced non-small-cell lung cancer.

Mellema WW, Masen-Poos L, Smit EF, Hendriks LE, Aerts JG, Termeer A, Goosens MJ, Smit HJ, van den Heuvel MM, van der Wekken AJ, Herder GJ, Krouwels FH, Stigt JA, van den Borne BE, Haitjema TJ, Staal-Van den Brekel AJ, van Heemst RC, Pouw E, Dingemans AM.

Lung Cancer. 2015 Nov;90(2):249-54. doi: 10.1016/j.lungcan.2015.09.012. Epub 2015 Sep 15.

PMID:
26415993
39.

Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study.

Hendriks LE, Derks JL, Postmus PE, Damhuis RA, Houben RM, Troost EG, Hochstenbag MM, Smit EF, Dingemans AM.

Eur J Cancer. 2015 Nov;51(17):2534-44. doi: 10.1016/j.ejca.2015.08.008. Epub 2015 Aug 28.

PMID:
26323530
40.

Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis.

Kuiper JL, Hendriks LE, van der Wekken AJ, de Langen AJ, Bahce I, Thunnissen E, Heideman DA, Berk Y, Buijs EJ, Speel EJ, Krouwels FH, Smit HJ, Groen HJ, Dingemans AM, Smit EF.

Lung Cancer. 2015 Sep;89(3):255-61. doi: 10.1016/j.lungcan.2015.05.023. Epub 2015 Jun 6.

PMID:
26117231
41.

Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trial.

Manders SH, Kievit W, Adang E, Brus HL, Moens HJ, Hartkamp A, Hendriks L, Brouwer E, Visser H, Vonkeman HE, Hendrikx J, Jansen TL, Westhovens R, van de Laar MA, van Riel PL.

Arthritis Res Ther. 2015 May 22;17:134. doi: 10.1186/s13075-015-0630-5.

42.

Safety of cranial radiotherapy concurrent with tyrosine kinase inhibitors in non-small cell lung cancer patients: A systematic review.

Hendriks LE, Schoenmaekers J, Zindler JD, Eekers DB, Hoeben A, De Ruysscher DK, Dingemans AM.

Cancer Treat Rev. 2015 Jul;41(7):634-45. doi: 10.1016/j.ctrv.2015.05.005. Epub 2015 May 13. Review.

PMID:
25990950
43.

Determinants associated with work participation in patients with established rheumatoid arthritis taking tumor necrosis factor inhibitors.

Manders SH, Kievit W, Braakman-Jansen AL, Brus HL, Hendriks L, Fransen J, van de Laar MA, van Riel PL.

J Rheumatol. 2014 Jul;41(7):1263-9. doi: 10.3899/jrheum.130878. Epub 2014 May 15.

PMID:
24833758
44.

Patient selection for whole brain radiotherapy (WBRT) in a large lung cancer cohort: Impact of a new Dutch guideline on brain metastases.

Hendriks LE, Troost EG, Steward A, Bootsma GP, De Jaeger K, van den Borne BE, Dingemans AM.

Acta Oncol. 2014 Jul;53(7):945-51. doi: 10.3109/0284186X.2014.906746. Epub 2014 Apr 23.

PMID:
24754845
45.

EGFR mutated non-small cell lung cancer patients: more prone to development of bone and brain metastases?

Hendriks LE, Smit EF, Vosse BA, Mellema WW, Heideman DA, Bootsma GP, Westenend M, Pitz C, de Vries GJ, Houben R, Grünberg K, Bendek M, Speel EJ, Dingemans AM.

Lung Cancer. 2014 Apr;84(1):86-91. doi: 10.1016/j.lungcan.2014.01.006. Epub 2014 Jan 23.

PMID:
24529684
46.
47.

Performance of the Dutch SF-36 version 2 as a measure of health-related quality of life in patients with rheumatoid arthritis.

ten Klooster PM, Vonkeman HE, Taal E, Siemons L, Hendriks L, de Jong AJ, Dutmer EA, van Riel PL, van de Laar MA.

Health Qual Life Outcomes. 2013 May 8;11:77. doi: 10.1186/1477-7525-11-77.

48.

Screening for brain metastases in patients with stage III non-small cell lung cancer: Is there additive value of magnetic resonance imaging above a contrast-enhanced computed tomography of the brain?

Hendriks LE, Bootsma GP, de Ruysscher DK, Scheppers NA, Hofman PA, Brans BT, Dingemans AM.

Lung Cancer. 2013 Jun;80(3):293-7. doi: 10.1016/j.lungcan.2013.02.006. Epub 2013 Mar 18.

PMID:
23518381
49.

[A man with persisting dyspnea].

Hendriks LE, Gronenschild MH, van Haren EH.

Ned Tijdschr Geneeskd. 2013;157(3):A5158. Dutch.

PMID:
23328016
50.

Qualitative and semiquantitative analysis of composite mixtures of antibodies by native mass spectrometry.

Rosati S, Thompson NJ, Barendregt A, Hendriks LJ, Bakker AB, de Kruif J, Throsby M, van Duijn E, Heck AJ.

Anal Chem. 2012 Aug 21;84(16):7227-32. doi: 10.1021/ac301611d. Epub 2012 Aug 10.

PMID:
22882109

Supplemental Content

Loading ...
Support Center